BibTex RIS Cite
Year 2014, Volume: 4 Issue: 2, 160 - 166, 01.06.2014

Abstract

Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections

Year 2014, Volume: 4 Issue: 2, 160 - 166, 01.06.2014

Abstract

The purpose of this study is to show how a private eye care center in Turkey initiated Six Sigma principles to reduce the number of complications encountered during and after intravitreal injections. Data were collected for 30-months. To analyse the complications among 229 injections administered on 106 patients, main tools of Six Sigma’s Define-Measure-Analyze-Improve-Control (DMAIC) improvement cycle such as SIPOC table, Fishbone Diagram and, Failure, Mode and Effect Analysis were implemented. Sources and root causes of seven types of complications were identified and reported. For a successful intravitreal injection, experience of the retina specialist, attention of the retina specialist and patient’s ocular pathology were determined to be the “critical few” factors whereas, sterilization and hygiene, dosage of drug/agent and chemical properties of drug/agent were found to be the “trivial many”factors. The most frequently occuring and the complication with the highest hazard score was found to be subconjunctival haemorrhage. The process sigma level of the process was measured to be 3.2657. The surgical team concluded that six of the complications (out of seven) should be significantly reduced by taking the necessary preventative measures.

There are 0 citations in total.

Details

Other ID JA97NK77PJ
Journal Section Research Article
Authors

İbrahim Sahbaz This is me

Mehmet Tolga Taner This is me

Mustafa Elıacık This is me

Gamze Kagan This is me

Engin Erbas This is me

Hazar Engunyurt This is me

Publication Date June 1, 2014
Published in Issue Year 2014 Volume: 4 Issue: 2

Cite

APA Sahbaz, İ., Taner, M. T., Elıacık, M., Kagan, G., et al. (2014). Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. International Review of Management and Marketing, 4(2), 160-166.
AMA Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. June 2014;4(2):160-166.
Chicago Sahbaz, İbrahim, Mehmet Tolga Taner, Mustafa Elıacık, Gamze Kagan, Engin Erbas, and Hazar Engunyurt. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing 4, no. 2 (June 2014): 160-66.
EndNote Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H (June 1, 2014) Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. International Review of Management and Marketing 4 2 160–166.
IEEE İ. Sahbaz, M. T. Taner, M. Elıacık, G. Kagan, E. Erbas, and H. Engunyurt, “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”, IRMM, vol. 4, no. 2, pp. 160–166, 2014.
ISNAD Sahbaz, İbrahim et al. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing 4/2 (June 2014), 160-166.
JAMA Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. 2014;4:160–166.
MLA Sahbaz, İbrahim et al. “Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections”. International Review of Management and Marketing, vol. 4, no. 2, 2014, pp. 160-6.
Vancouver Sahbaz İ, Taner MT, Elıacık M, Kagan G, Erbas E, Engunyurt H. Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. IRMM. 2014;4(2):160-6.